Recent Developments in Basal Insulin Therapy for Adult Type 2 Diabetes: What do They Mean for Clinical Practice
18th November 2015
For nurses specialising in diabetes
For nurses specialising in diabetes
For nurses specialising in diabetes
For nurses specialising in diabetes
For nurses specialising in diabetes
For nurses specialising in diabetes
For nurses specialising in diabetes
For nurses specialising in diabetes
For nurses specialising in diabetes
Sanofi’s Toujeo® (Insulin glargine 300 units/mL) has been approved for use in Scotland, the pharmaceutical company has announced. The Scottish Medicines Consortium (SMC) has approved the ...
For nurses specialising in diabetes